C1q-TNF-related protein-9, a novel cardioprotetcive cardiokine, requires proteolytic cleavage to generate a biologically active globular domain isoform

American Journal of Physiology. Endocrinology and Metabolism
Yuexing YuanXin-Liang Ma

Abstract

Prevalence and severity of postmyocardial infarction heart failure continually escalate in type 2 diabetes via incompletely understood mechanisms. The discovery of the cardiac secretomes, collectively known as "cardiokines", has significantly enhanced appreciation of the local microenvironment's influence on disease development. Recent studies demonstrated that C1q-TNF-related protein-9 (CTRP9), a newly discovered adiponectin (APN) paralog, is highly expressed in the heart. However, its relationship with APN (concerning diabetic cardiovascular injury in particular) remains unknown. Plasma CTRP9 levels are elevated in APN knockout and reduced in diabetic mice. In contrast to APN, which circulates as full-length multimers, CTRP9 circulates in the plasma primarily in the globular domain isoform (gCTRP9). Recombinant full-length CTRP9 (fCTRP9) was cleaved when incubated with cardiac tissue extracts, generating gCTRP9, a process inhibited by protease inhibitor cocktail. gCTRP9 rapidly activates cardiac survival kinases, including AMPK, Akt, and endothelial NOS. However, fCTRP9-mediated kinase activation is much less potent and significantly delayed. Kinase activation by fCTRP9, but not gCTRP9, is inhibited by protease inhibitor cock...Continue Reading

References

Jan 14, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Masahiro KumadaUNKNOWN Osaka CAD Study Group. Coronary artery disease
Apr 15, 2004·JAMA : the Journal of the American Medical Association·Tobias PischonEric B Rimm
Jul 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Guang W WongHarvey F Lodish
Jan 27, 2007·Current Diabetes Reports·Barry J Goldstein, Rosario Scalia
Jun 5, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Margaret P ChandlerMartin E Young
Sep 13, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·G William WongHarvey F Lodish
Nov 8, 2008·The Biochemical Journal·Kathryn E Davis, Philipp E Scherer
Dec 19, 2008·The New England Journal of Medicine·William DuckworthUNKNOWN VADT Investigators
Apr 21, 2009·Methods in Molecular Biology·Magda GioiaChristopher M Overall
Dec 24, 2009·American Journal of Physiology. Endocrinology and Metabolism·Yajing WangXin-Liang Ma
Feb 1, 2011·Trends in Molecular Medicine·Shirin Doroudgar, Christopher C Glembotski
Jan 21, 2012·Trends in Endocrinology and Metabolism : TEM·Andreas Schäffler, Christa Buechler
Feb 18, 2012·Circulation. Cardiovascular Genetics·Miroslava Stastna, Jennifer E Van Eyk
Feb 22, 2012·The Journal of Biological Chemistry·Marcus M SeldinG William Wong
Mar 6, 2012·Cell Stem Cell·Sudhir H RanganathJeffrey M Karp
Nov 22, 2012·Circulation·Masayuki ShimanoKenneth Walsh
Dec 5, 2012·Nature Reviews. Cardiology·Karl T WeberIvan C Gerling
Aug 22, 2013·Reviews in Endocrine & Metabolic Disorders·Marcus M SeldinG William Wong
Jan 30, 2014·American Journal of Physiology. Endocrinology and Metabolism·Zhikui WeiG William Wong

❮ Previous
Next ❯

Citations

Jun 2, 2016·Journal of the American Heart Association·Colleen M DeweyChad E Grueter
Nov 9, 2016·Circulation Research·Mahesh AppariJoerg Heineke
Feb 16, 2019·Journal of the American Heart Association·Yunhui DuHuirong Liu
Jun 13, 2017·Circulation Journal : Official Journal of the Japanese Circulation Society·Wayne Bond LauNoriyuki Ouchi
May 11, 2018·BioMed Research International·Ye-Shun WuChun Yang
Mar 12, 2017·Journal of Molecular Endocrinology·Guokun YangWensheng Li
Dec 30, 2020·Journal of the American Heart Association·Leonardo MacielDebora Foguel
Dec 8, 2020·Frontiers in Cardiovascular Medicine·Ibrahim AlZaimAhmed F El-Yazbi
Mar 5, 2021·Human & Experimental Toxicology·P LiX Huang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.